Adrenomed AG
PrivateLast Round
Series E
Nov 30, 2020
Total Funding Raised
$53.77M
Company Overview
Adrenomed AG is a biopharmaceutical company that develops a first-in-class antibody to rescue vascular integrity in critically ill patients.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Precision Medicine, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Adrenomed AG Comparables
Compare Adrenomed AG with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Inotrem | 88% | |
| 4TEEN4 Pharmaceuticals GmbH | 87% | |
| Matisse Pharmaceuticals | 83% | |
Adrenomed AG Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series E | Nov 30, 2020 | ||||
| Series D | Nov 26, 2018 |
Key People
Founding team and executive leadership
Adrenomed AG Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Investitionsbank des Landes Brandenburg | Series D |
| HBM Healthcare Investments | Debt, Series E, Series D |
| Wellington Partners | Debt, Series E, Series D |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 5, 2026
Monthly visitors grew 81% MoM.
- May 4, 2025
Monthly visitors grew 75% MoM.
Adrenomed AG Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Adrenomed AG's valuation, stock price, and market status.